Skip to main content
News Directory 3
  • Business
  • Entertainment
  • Health
  • News
  • Sports
  • Tech
  • World
Menu
  • Business
  • Entertainment
  • Health
  • News
  • Sports
  • Tech
  • World
Iron Dysregulation & Ferroptosis: Pulmonary Fibrosis Targets - News Directory 3

Iron Dysregulation & Ferroptosis: Pulmonary Fibrosis Targets

August 30, 2025 Jennifer Chen Health
News Context
At a glance
Original source: ajmc.com

ferroptosis: ⁢A Potential New Target for Pulmonary Fibrosis Treatment

Pulmonary fibrosis (PF) is a severe lung disease with a poor prognosis, currently managed ‍with treatments that only slow progression, ⁣and lung transplantation as the only definitive option. Though, research is increasingly focusing on ferroptosis – a regulated, iron-dependent form of cell death – as a key driver of PF development and ⁤a potential therapeutic target.Here’s a breakdown of the key points:

What⁤ is Ferroptosis? It’s a type of programmed‍ cell death caused by⁤ iron-dependent ⁣lipid peroxidation, leading to oxidative damage to cell membranes. It differs⁤ from apoptosis.
Why is⁢ it relevant to PF? Oxidative⁢ stress and iron overload in the lungs trigger ferroptosis in crucial lung cells (alveolar epithelial cells, macrophages, and fibroblasts), contributing to scarring and fibrosis.
Evidence ‍supporting the link:
Research shows ferroptosis contributes to macrophage polarization, fibroblast ⁤proliferation, ECM deposition, and ultimately, alveolar cell death.
Animal studies demonstrate that iron chelators and ferroptosis inhibitors can reduce fibrosis by protecting epithelial cells, suppressing inflammation, and limiting ⁢fibroblast activation. How it affects different lung cells:
Alveolar Epithelial Cells (aecs): Iron overload weakens their ability to repair damage, and their ferroptosis promotes⁤ abnormal healing and fibrosis. Drugs⁤ like deferoxamine⁤ and liproxstatin-1 show promise in protecting AECs. Alveolar Macrophages (AMs): Iron-laden macrophages accumulate in fibrotic lungs ‍and release factors that promote fibrosis.
Broader Implications: Ferroptosis appears to be a ⁢common mechanism in fibrotic diseases affecting the ⁢lungs, liver, ‍and kidneys, suggesting ⁣potential for therapies⁤ developed for PF to have wider applications.

In essence, targeting ferroptosis pathways coudl offer⁤ a new approach to treating PF, possibly halting or even reversing the disease process.

Sources:

  1. ⁣ Review published in ⁤ Molecules and Cells*: https://www.sciencedirect.com/science/article/pii/S1016847825000883
  2. Previous research: https://pubmed.ncbi.nlm.nih.gov/38914560/

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Related

pulmonary fibrosis, pulmonary fibrosis progression, targets in pulmonary fibrosis

Search:

News Directory 3

News Directory 3 catalogs US newspapers, news services, newsstands and digital news outlets across all 50 states. Browse local publishers by city, state, or topic, and follow current headlines linked back to their original sources.

Quick Links

  • Disclaimer
  • Terms and Conditions
  • About Us
  • Advertising Policy
  • Contact Us
  • Cookie Policy
  • Editorial Guidelines
  • Privacy Policy

Browse by State

  • Alabama
  • Alaska
  • Arizona
  • Arkansas
  • California
  • Colorado

© 2026 News Directory 3. All rights reserved.
For contact, advertising, copyright, issues email: office@newsdirectory3.com